TNF inhibitors linked to greater risk for inflammatory central nervous system events

The use of TNF inhibitors among patients with autoimmune disease may be associated with an increased risk for inflammatory central nervous system events, according to data published in JAMA Neurology.“After the introduction of TNF inhibitors, several studies reported an association between TNF inhibitors and inflammatory demyelinating central nervous system (CNS) events such as optic neuritis,…

IBD associated with higher dementia risk

Patients with inflammatory bowel disease were at greater risk for developing dementia, according to research published in Gut.Yen-Po Wang, MD, of Taipei Veterans General Hospital, and colleagues wrote that psychological conditions such as anxiety and depression are common in IBD, but the relationship between IBD and dementia is not as well explored.“Characteristics of IBD include…

Lanifibranor meets efficacy, safety endpoints in phase 2b NASH trial

Inventiva announced lanifibranor met primary and secondary endpoints in a phase 2b study for treatment of nonalcoholic steatohepatitis, according to speaker at an Inventiva web conference.“Lanifibranor (1,200 mg) met the primary endpoints with a statistically significant reduction, after 6 months of treatment, of the Steatosis Activity Fibrosis score, which combines assessments of hepatocellular inflammation and…

Survey: US adults changing eating habits during COVID-19

More than 40% of parents in the United States are snacking more during the COVID-19 pandemic, data from the International Food Information Council Foundation’s 2020 Food and Health Survey show.“Physicians are trusted sources of information, so checking in on patients’ needs and sharing science-based information is really important,” Ali Webster, PhD, RD, the council’s director…